Elicio Therapeutics
IPOLymph Node-Targeted Immunotherapies
Public · United States · $45.6M raised
- Business Model
- B2B
- Website
- elicio.com
- Total Funding
- $45.6M
- Last Round
- $10.0M Venture RoundJun 2025
- Rounds
- 3
- Type
- Public
About
Biotech company developing lymph node-targeted AMP-powered immunotherapies for cancer treatment.
Summary
Elicio Therapeutics is a Biotech company based in United States. It has raised $45.6M in total across 3 rounds, most recently a $10.0M Venture Round round in Jun 2025. Investors include Gastro-Intestinal Research Foundation and Livzon Pharmaceutical Group.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2025
Sign up to see all 3 rounds
Series B through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/elicio-therapeutics"><img src="https://indexed.vc/api/badge/company/elicio-therapeutics" alt="Elicio Therapeutics on Indexed.vc" width="260" height="76" /></a>